GC Asia
-
Chinese pharma names flock to ECM market
There was a burst of activity from Chinese pharmaceutical and biotechnology companies in the equity capital markets this week, as the sector took centre stage following the spread of a flu-like virus that has already claimed lives on the mainland. Jonathan Breen reports.
23 Jan 2020 -
Zai Lab, Hutchison Chi-Med launch ADS follow-ons
Chinese biopharmaceutical company Zai Lab has kicked off a follow-on offering of its American Depository Shares. It is aiming to raise around $300m.
22 Jan 2020 -
Intu preps rescue rights issue but needs a long-term plan
Intu, the British real estate and investment trust focused on shopping centres, has confirmed it will be tapping its shareholders for equity capital in February, but sources say the company needs to outline its vision for its future, given the headwinds buffeting the UK retail sector.
21 Jan 2020 -
Beijing Capital Land nets $119m from HK rights issue
Chinese real estate developer Beijing Capital Land has raised HK$925.3m ($119.1m) from the H-share portion of a three-tranche rights issue.
21 Jan 2020 -
Guotai Junan eyes HK$3.8bn rights issue
Guotai Junan International Holdings is planning a rights issue of new shares as it looks to raise up to HK$3.75bn ($482.3m).
15 Jan 2020 -
Seazen pockets $351m from HK placement
Chinese property developer Seazen Group raised HK$2.73bn ($351.3m) on Monday from a sale of new shares, increasing the offering size on the back of strong demand, according to a source familiar with the deal.
14 Jan 2020 -
Luckin Coffee nabs $980m from bigger CB, follow-on combo
China’s challenger to Starbucks, Luckin Coffee, has raised $979.6m after increasing the size of a combined sale of new shares and a convertible bond, the first tap of the ADS equity-linked market in 2020.
13 Jan 2020 -
Yes Bank stock dives as $1.4bn deal wins board nod
Yes Bank's share price collapsed in Monday morning trading after the Indian lender’s board of directors approved a potential billion-dollar equity fundraising.
13 Jan 2020 -
Sunac China and WuXi Bio tap Hong Kong for $1.8bn
Mainland-based property developer Sunac China Holdings has raised HK$8bn ($1.03bn) after issuing a chunk of new shares.
10 Jan 2020 -
Investors put in jumbo orders for Airtel’s $3bn QIP, CB combo
Indian telecommunications giant Bharti Airtel made a splash in the equities market this week, bagging $2bn from a qualified institutional placement (QIP) and $1bn from a convertible bond, the first equity-linked issue in the country in more than two years. Both the deals received a big thumbs-up from investors, reports Jonathan Breen.
09 Jan 2020
